Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221094 | SCV000274974 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000419582 | SCV000512148 | benign | not specified | 2015-05-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000538068 | SCV000622363 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000419582 | SCV000694236 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000221094 | SCV001356462 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000221094 | SCV002532863 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-01 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004589958 | SCV005082724 | benign | Familial cancer of breast | 2024-05-10 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Natera, |
RCV000538068 | SCV002076370 | likely benign | Ataxia-telangiectasia syndrome | 2021-07-15 | no assertion criteria provided | clinical testing |